Generation Bio Co. (GBIO)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.4271 +0.0065 (+1.55%) 04/25/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.4184 -0.0087 (-2.04%) 17:50 ET
for Fri, Apr 25th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Cash Flows From Operating Activities | |||||
Net Income | -131,668 | -126,612 | -136,639 | -119,151 | -80,523 |
Depreciation Amortization | 4,931 | 5,263 | 5,130 | 4,532 | 3,432 |
Accounts receivable | N/A | -3,565 | -395 | N/A | 448 |
Accounts payable and accrued liabilities | -386 | 1,087 | -1,386 | 1,756 | -1,444 |
Other Working Capital | -31,429 | 53,537 | 1,046 | 4,175 | -1,712 |
Other Operating Activity | 69,989 | 17,545 | 29,796 | 16,867 | 9,657 |
Operating Cash Flow | $-88,563 | $-52,745 | $-102,448 | $-91,821 | $-70,142 |
Cash Flows From Investing Activities | |||||
PPE Investments | -2,205 | -7,397 | -8,801 | -5,853 | -5,518 |
Purchase Of Investment | -135,266 | -405,301 | -323,714 | N/A | -243,178 |
Sale Of Investment | 232,000 | 403,000 | 140,000 | 198,900 | 43,500 |
Investing Cash Flow | $94,529 | $-9,698 | $-192,515 | $193,047 | $-205,196 |
Cash Flows From Financing Activities | |||||
Common Stock Issued | 436 | 36,546 | 13,620 | 215,626 | 217,467 |
Other Financing Activity | -186 | -729 | -631 | -955 | 105,628 |
Financing Cash Flow | $250 | $35,817 | $12,989 | $214,671 | $323,095 |
Beginning Cash Position | 72,237 | 98,863 | 380,837 | 64,940 | 17,183 |
End Cash Position | 78,453 | 72,237 | 98,863 | 380,837 | 64,940 |
Net Cash Flow | $6,216 | $-26,626 | $-281,974 | $315,897 | $47,757 |
Free Cash Flow | |||||
Operating Cash Flow | -88,563 | -52,745 | -102,448 | -91,821 | -70,142 |
Capital Expenditure | -2,401 | -7,397 | -8,801 | -5,958 | -5,518 |
Free Cash Flow | -90,964 | -60,142 | -111,249 | -97,779 | -75,660 |